Fairmount Funds Management Llc Aeglea Bio Therapeutics, Inc. (AGLE) insider trading activity

Fairmount Funds Management LLC Transaction History

Date	Transaction	Value	Shares Traded
Apr 25 2024	BUY Exercise of conversion of derivative security	-	3,639,680
Dec 29 2023	SELL Other acquisition or disposition	-	3,435,480
Dec 29 2023	BUY Other acquisition or disposition	-	812,076
Nov 24 2023	BUY Conversion of derivative security	-	3,435,480

COGT

Cogent Biosciences, Inc. Healthcare

VRDN

Viridian Therapeutics, Inc.\DE Healthcare

Director

APGE

Apogee Therapeutics, Inc.

Director

MGTA

Magenta Therapeutics, Inc. Healthcare

Director

ABIO

ARCA biopharma, Inc. Healthcare

Director

ZBIO

Zenas BioPharma, Inc.

Director

FFM

Philadelphia, PA

Receive a notification when an Institution or Guru buys or sells AGLE shares.

Notify only if

Value

Get notified when an Aeglea Bio Therapeutics, Inc. insider buys or sells AGLE shares.

Notify only if

Operation

Value

Type

Receive news related to Aeglea BioTherapeutics, Inc.